Molecular and transcriptional basis of bidirectional CD4⁺ T cell exhaustion in oropharyngeal squamous cell carcinoma

Abstract

Tumor-infiltrating CD4⁺ T cells orchestrate the adaptive immune response through remarkable plasticity, and the expression patterns of exhaustion-related inhibitory receptors in these cells differ significantly from those of CD8⁺ T cells. Thus, a better understanding of the molecular basis of CD4⁺ T cell exhaustion and their responses to immune checkpoint blockade (ICB) is required. Here, we integrated multiomics approaches to define the phenotypic and molecular profiles of exhausted CD4⁺ T cells in oropharyngeal squamous cell carcinoma (OPSCC). Two distinct immune-promoting (Module 1) and immunosuppressive (Module 2) functional modules in tumor-infiltrating CD4⁺ T cells were identified, and both the immune-promoting function of Module 1 cells and immunosuppressive function of Module 2 cells were positively associated with their corresponding exhaustion states. Furthermore, the application of ICBs targeting effector CD4⁺ T cells in Module 1 (αPD-1) and Treg cells in Module 2 (αCTLA-4) in mouse models could help reinvigorate the effector function of Module 1-exhausted CD4⁺ T cells and reduce the immunosuppressive function of Module 2-exhausted CD4⁺ T cells, ultimately promoting OPSCC tumor regression. Taken together, our study provides a crucial cellular basis for the selection of optimal ICB in treating OPSCC.

Keywords

CD4-positive T-lymphocytes / head and neck cancer / immune checkpoint inhibitors / T cell exhaustion / tumor microenvironment

References

1	DF Quail, JA Joyce. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423-1437.
2	J Borst, T Ahrends, N B?ba?a, CJM Melief, W Kastenmüller. CD4+ T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18:635-647.
3	H-J Kim, H Cantor. CD4 T-cell subsets and tumor immunity: the helpful and the not-so-helpful. Cancer Immunol Res. 2014;2:91-98.
4	CU Blank, WN Haining, W Held, et al. Defining ‘’T cell exhaustion. Nat Rev Immunol. 2019;19:665-674.
5	EJ Wherry, M Kurachi. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486-499.
6	Ke Qiu, X Duan, M Mao, et al. mRNA-LNP vaccination-based immunotherapy augments CD8+ T cell responses against HPV-positive oropharyngeal cancer. NPJ Vaccines. 2023;8:144.
7	AR Cillo, et al. Immune landscape of viral- and carcinogen-driven head and neck cancer. Immunity. 2020;52:183-199. e9.
8	HS Quah, EY Cao, L Suteja, et al. Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis. Nat Commun. 2023;14:1680.
9	SC Formenti, RE Hawtin, N Dixit, et al. Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients. J Immunother Cancer. 2019;7:177.
10	H Li, Ke Wu, K Tao, et al. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology. 2012;56:1342-1351.
11	M Nakano, M Ito, R Tanaka, et al. PD -1+ TIM -3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer. Cancer Sci. 2018;109:2986-2992.
12	W Shi, Bo Yang, Q Sun, et al. PD-1 regulates CXCR5+ CD4 T cell-mediated proinflammatory functions in non-small cell lung cancer patients. Int Immunopharmacol. 2020;82:106295.
13	WW Reiley, S Shafiani, ST Wittmer, et al. Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA. 2010;107:19408-19413.
14	PM Odorizzi, EJ Wherry. Inhibitory receptors on lymphocytes: insights from infections. J Immunol. 2012;188:2957-2965.
15	N Chihara, A Madi, T Kondo, et al. Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature. 2018;558:454-459.
16	K Catakovic, FJ Gassner, C Ratswohl, et al. TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia. OncoImmunology. 2018;7:e1371399.
17	SR Goding, KA Wilson, Y Xie, et al. Restoring immune function of tumor-specific CD4 + T cells during recurrence of melanoma. J Immunol. 2013;190:4899-4909.
18	SG Kalathil, K Wang, A Hutson, R Iyer, Y Thanavala. Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients. OncoImmunology. 2020;9:1824863.
19	DE Lowther, BA Goods, LE Lucca, et al. PD-1 marks dysfunctional regulatory T cells in malignant gliomas. JCI Insight. 2016;1.
20	KE Pauken, EJ Wherry. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 2015;36:265-276.
21	HM Zarour. Reversing T-cell dysfunction and exhaustion in cancer. Clin Cancer Res. 2016;22:1856-1864.
22	G Oliveira, K Stromhaug, N Cieri, et al. Landscape of helper and regulatory antitumour CD4+ T cells in melanoma. Nature. 2022;605:532-538.
23	A Crawford, JM Angelosanto, C Kao, et al. Molecular and transcriptional basis of CD4+ T cell dysfunction during chronic infection. Immunity. 2014;40:289-302.
24	AC Belkina, CO Ciccolella, R Anno, R Halpert, J Spidlen, JE Snyder-Cappione. Automated optimized parameters for T-distributed stochastic neighbor embedding improve visualization and analysis of large datasets. Nat Commun. 2019;10:5415.
25	SR Goding, KA Wilson, C Rosinsky, PA Antony. PD-L1-independent mechanisms control the resistance of melanoma to CD4 + T cell adoptive immunotherapy. J Immunol. 2018;200:3304-3311.
26	C-C Balan?a, A Salvioni, C-M Scarlata, et al. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells. JCI Insight. 2021;6:e142513.
27	SC Wei, N-AAS Anang, R Sharma, et al. Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies. Proc Natl Acad Sci USA. 2019;116:22699-22709.
28	GXY Zheng, JM Terry, P Belgrader, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049.
29	Y Hao, S Hao, E Andersen-Nissen, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573-3587. e29.
30	J Alquicira-Hernandez, JE Powell. Nebulosa recovers single-cell gene expression signals by kernel density estimation. Bioinformatics. 2021;37:2485-2487.
31	J Cao, M Spielmann, X Qiu, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566:496-502.
32	N Borcherding, NL Bormann, G Kraus. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Research. 2020;9:47.
33	D Cheng. Proliferative exhausted CD8+ T cells exacerbate long-lasting anti-tumor effects in human papillomavirus-positive head and neck squamous cell carcinoma. eLife. 2023;12:e82705.
34	Y Zeng, C Liu, Y Gong, et al. Single-cell RNA sequencing resolves spatiotemporal development of pre-thymic lymphoid progenitors and thymus organogenesis in human embryos. Immunity. 2019;51:930-948. e6.
35	DY Oh, SS Kwek, SS Raju, et al. Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell. 2020;181:1612-1625. e13.
36	E Cano-Gamez, B Soskic, TI Roumeliotis, et al. Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines. Nat Commun. 2020;11:1801.
37	N Gutiérrez-Melo, D Baumjohann. T follicular helper cells in cancer. Trends Cancer. 2023;9:309-325.
38	C Gu-Trantien, E Migliori, L Buisseret, et al. CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. JCI Insight. 2017;2:e91487. 91487.
39	T Wu, E Hu, S Xu, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2:100141.